XGEN PHARMS FDA Approval ANDA 206982

ANDA 206982

XGEN PHARMS

FDA Drug Application

Application #206982

Application Sponsors

ANDA 206982XGEN PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION300MG/VIAL0PENTAMIDINE ISETHIONATEPENTAMIDINE ISETHIONATE

FDA Submissions

UNKNOWN; ORIG1AP2022-03-17STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

XGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206982
            [companyName] => XGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PENTAMIDINE ISETHIONATE","activeIngredients":"PENTAMIDINE ISETHIONATE","strength":"300MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/17\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-03-17
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.